Search Results - Michael C. Heinrich

Refine Results
  1. 1
    Dynamic sorting of lipids and proteins in membrane tubes with a moving phase boundary

    Dynamic sorting of lipids and proteins in membrane tubes with a moving phase boundary by Michael C. Heinrich, Aiwei Tian, Cinzia Esposito, Tobias Baumgart

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors

    Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors by Ann W. Gramza, Christopher L. Corless, Michael C. Heinrich

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Translational insights into gastrointestinal stromal tumor and current clinical advances

    Translational insights into gastrointestinal stromal tumor and current clinical advances by Matthew L. Hemming, Michael C. Heinrich, Sebastian Bauer, Suzanne George

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor

    Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor by Sebastian Bauer, Suzanne George, Margaret von Mehren, Michael C. Heinrich

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Paraganglioma of the Head and Neck: A Review

    Paraganglioma of the Head and Neck: A Review by Lyndsey Sandow, Rajat Thawani, Myung‐Sun Kim, Michael C. Heinrich

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Q<i>uadruple</i> wild‐type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways

    Q<i>uadruple</i> wild‐type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways by Maria A. Pantaleo, Margherita Nannini, Christopher L. Corless, Michael C. Heinrich

    Published 2014
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  7. 7
    Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach

    Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach by Robert J. Coffey, M. Kay Washington, Christopher L. Corless, Michael C. Heinrich

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size

    KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size by Christopher L. Corless, Laura McGreevey, Andrea Haley, Ajia Town, Michael C. Heinrich

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms

    Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms by Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut, Hartmut Döhner, Konstanze Döhner, Marcus M. Schittenhelm

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors

    Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors by Michael C. Heinrich, Diana Griffith, Arin McKinley, Janice Patterson, Ajia Presnell, Abhijit Ramachandran, Maria Dębiec‐Rychter

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit

    Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit by Anne E. Rader, Anne C. Avery, Cecily L. Wait, Laura McGreevey, Douglas O. Faigel, Michael C. Heinrich

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping

    Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping by Carol Beadling, Tanaya Neff, Michael C. Heinrich, Katherine Rhodes, Michael Thornton, John H. Leamon, Mark T. Andersen, Christopher L. Corless

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance

    BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance by Gerald S. Falchook, Jonathan C. Trent, Michael C. Heinrich, Carol Beadling, J. W. Patterson, Christel C. Bastida, S Blackman, Razelle Kurzrock

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia

    Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia by Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut, Katharina Henriette Rasp, Barbara Illing, Hartmut Döhner, Konstanze Döhner, Marcus M. Schittenhelm

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    The Fanconi Anemia Group C Gene Product Is Located in Both the Nucleus and Cytoplasm of Human Cells

    The Fanconi Anemia Group C Gene Product Is Located in Both the Nucleus and Cytoplasm of Human Cells by Maureen E. Hoatlin, Tracy A. Christianson, Winnie W. Keeble, Adam T. Hammond, Yu Zhi, Michael C. Heinrich, Paula A. Tower, Grover C. Bagby

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells

    Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells by Kevin Yee, Marcus M. Schittenhelm, Anne-Marie O'Farrell, Ajia Town, Laura McGreevey, Troy Bainbridge, Julie M. Cherrington, Michael C. Heinrich

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Heterogeneity of kinase inhibitor resistance mechanisms in GIST

    Heterogeneity of kinase inhibitor resistance mechanisms in GIST by Bernadette Liegl, Ilana Kepten, Claudia Le, Mei‐Jun Zhu, George D. Demetri, Michael C. Heinrich, CDM Fletcher, Christopher L. Corless, JA Fletcher

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Pediatric <i>KIT</i>–Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal Tumors

    Pediatric <i>KIT</i>–Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progressio... by Katherine A. Janeway, Bernadette Liegl, Amy Harlow, Claudia Le, Antonio R. Pérez‐Atayde, Harry Kozakewich, Christopher L. Corless, Michael C. Heinrich, Jonathan A. Fletcher

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast

    High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast by Megan L. Troxell, Judith Levine, Carol Beadling, Andrea Warrick, Jennifer Dunlap, Ajia Presnell, Janice Patterson, Arielle Shukla, Neal Olson, Michael C. Heinrich, Christopher L. Corless

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

    SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase by Kevin Yee, A O’Farrell, Beverly D. Smolich, Julie M. Cherrington, Gerald McMahon, Cecily L. Wait, Laura McGreevey, Diana Griffith, Michael C. Heinrich

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: